We are live on ! Find out more
MRNA icon

Moderna
MRNA

79 hedge funds and large institutions have $2.01B invested in Moderna in 2018 Q4 according to their latest regulatory filings, with 79 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more call options, than puts

Call options by funds: $22K | Put options by funds: $3K

40.61% more ownership

Funds ownership: 0% → 40.61% (+41%)

Holders
79
Holders Change
+79
Holders Change %
–
% of All Funds
1.76%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.11%
New
79
Increased
–
Reduced
–
Closed
–
Calls
$22K
Puts
$3K
Net Calls
+$19K
Net Calls Change
+$19K

Top Buyers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
+$966M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$281M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$251M
4
AG
Artal Group
Luxembourg
+$86.4M
5
BB
BB Biotech
Switzerland
+$78.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
26
Samlyn Capital
New York
$4.96M +$5.34M +325,000 New
Man Group
27
Man Group
United Kingdom
$4.81M +$5.18M +315,301 New
LCM
28
Laurion Capital Management
New York
$3.82M +$4.11M +250,000 New
ACH
29
ArrowMark Colorado Holdings
Colorado
$3.2M +$3.45M +209,759 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$3.09M +$3.33M +202,492 New
MAM
31
Myriad Asset Management
Hong Kong
$2.92M +$3.14M +190,943 New
Millennium Management
32
Millennium Management
New York
$2.71M +$2.91M +177,240 New
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$2.1M +$2.26M +137,349 New
AC
34
Athos Capital
Hong Kong
$2.01M +$2.17M +131,768 New
EDRH
35
Edmond de Rothschild Holding
Switzerland
$1.68M +$1.81M +110,000 New
HH
36
HSG Holding
Hong Kong
$1.39M +$1.5M +91,195 New
VIA
37
Vident Investment Advisory
Georgia
$1.29M +$1.39M +84,390 New
Legal & General Group
38
Legal & General Group
United Kingdom
$1.18M +$1.28M +77,637 New
WMSA
39
Weiss Multi-Strategy Advisers
New York
$878K +$945K +57,500 New
MF
40
Magnetar Financial
Illinois
$764K +$822K +50,000 New
Point72 Asset Management
41
Point72 Asset Management
Connecticut
$764K +$822K +50,000 New
Bank of America
42
Bank of America
North Carolina
$611K +$657K +40,008 New
PHK
43
Point72 Hong Kong
Hong Kong
$509K +$548K +33,319 New
BlackRock
44
BlackRock
New York
$391K +$421K +25,638 New
Susquehanna International Group
45
Susquehanna International Group
Pennsylvania
$389K +$419K +25,494 New
SGH
46
Sivik Global Healthcare
Connecticut
$382K +$411K +25,000 New
NSEDCP
47
NJ State Employees Deferred Compensation Plan
New Jersey
$305K +$329K +20,000 New
PCM
48
Pentwater Capital Management
Florida
$305K +$329K +20,000 New
BM
49
Brandywine Managers
Delaware
$246K +$265K +16,100 New
BFM
50
Boothbay Fund Management
New York
$229K +$247K +15,000 New
1
2
3 4

MRNA Hedge Fund Activity: Q4 2018 in Review

79 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q4 2018, worth a combined $2.01B.

Buyers outnumbered sellers: 79 funds opened new MRNA positions and 0 closed out — a net gain of 79 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Flagship Pioneering, opening a new position worth an estimated $966M.

  • 79 institutional investors held Moderna (MRNA) as of Q4 2018, up from 0 in Q3 2018.
  • Funds reported $2.01B of Moderna stock for Q4 2018.
  • 79 funds opened new Moderna positions in Q4 2018 and 0 closed out, a net change of +79 holders.
  • The largest Moderna buyer in Q4 2018 was Flagship Pioneering, an estimated $966M added.

Based on aggregated 13F filings for Q4 2018.